Bimanual Robotic Exoskeletal Platform for the Treatment of the Upper Limb in Patients With Stroke. A Feasibility Study (Birehab)

April 22, 2022 updated by: Lucia Lencioni, Wearable Robotics srl.

Pilot Study on the Evaluation of the Functionality, Safety and Feasibility of a Bimanual Robotic Exoskeletal Platform for the Treatment of the Upper Limb in Patients With Stroke

The purpose of the study is to test the technical functionality, safety, and feasibility of a bimanual robotic exoskeletal platform and associated serious games in order to offer information on technological and functional advances that will be included in the device's finalization.

In addition, a secondary goal will be to assess the therapeutic effects of a rehabilitation therapy based on the bimanual configuration, comparing it to a unimanual treatment delivered on the same platform (using the specific configuration).

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Rome, Italy, 00168
        • Recruiting
        • Fondazione Don Carlo Gnocchi
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 85 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • height between 150 and 190 cm;
  • weight not exceeding 130 kg;
  • ischemic injury;
  • first cortical and supra-tentorial event;
  • moderate motor deficit of the upper limb (score on the Fugl-Meyer Assessment - Upper Extremity between 29 and 42);
  • time since stroke event between 1 and 6 months;
  • trunk control test score greater than or equal to 48;
  • healthy bone density and skeleton that does not suffer from unhealed fractures.

Exclusion Criteria:

  • Relevant medical comorbidities (severe neurological diseases, cardiovascular diseases, diabetes / unstabilized hypertension);
  • Cognitive impairment that prevents understanding of the exercises administered;
  • Unavailability to provide informed consent;
  • Pregnant women;
  • Severe spasticity (Ashworth 4);
  • Major muscle contractures;
  • Excessive asymmetry in the length of the arms;
  • Upper limb prostheses;
  • Excessive joint limitations that make it difficult or painful to use the device;
  • Use of pacemakers or implantation of active devices;
  • Patients who already participate in another clinical study or who are already undergoing another similar robotic rehabilitation treatment.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Bimanual group
In this group, patients will perform a robotic rehabilitation based on bimanual serious games
Patients will undergo a bimanual 30-session robotic rehabilitation, using the robot ALEx RS with the bimanual configuration and the related serious games. Each session will last 45 minute. Daily sessions will be provided, five days a week.
Active Comparator: Unimanual group
In this group, patients will perform a robotic rehabilitation based on unimanual serious games
Patients will undergo a unimanual 30-session robotic rehabilitation, using the robot ALEx RS with the unimanual configuration and the related serious games.Daily sessions will be provided, five days a week.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of adverse events and description
Time Frame: through the study, an average of 10 months
Number and description of adverse events related to the provided intervention
through the study, an average of 10 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
System Usability Scale
Time Frame: After a 6-week robotic rehabilitation intervention
It is a self-administered questionnaire to evaluate usability. It ranges from 0 to 100. Higher scores mean better usability.
After a 6-week robotic rehabilitation intervention
Technology Acceptance Model (TAM)
Time Frame: After a 6-week robotic rehabilitation intervention

It is a self-administered questionnaire to evaluate the acceptance of the provided.

It comprises several questions rated on a 7-point likert scale.

After a 6-week robotic rehabilitation intervention
Likert for Satisfaction
Time Frame: After a 6-week robotic rehabilitation intervention
Satisfaction will be assessed using a 11-point likert scale. It ranges from 0 to 10. Higher scores mean higher satisfaction.
After a 6-week robotic rehabilitation intervention
Changes in Fugl-meyer Assessment Upper Extremity motor functioning
Time Frame: Before the intervention, after a 6-week robotic rehabilitation intervention
It is a stroke-specific, performance-based impairment index. It ranges from 0 (hemiplegia) to 66 points (normal).
Before the intervention, after a 6-week robotic rehabilitation intervention
Changes in Action Research Arm Test (ARAT)
Time Frame: Before the intervention, after a 6-week robotic rehabilitation intervention
It is a valid measure of upper-extremity functional limitation. The total score on the ARAT ranges from 0 to 57, with the lowest score indicating that no movements can be performed, and the upper score indicating normal performance.
Before the intervention, after a 6-week robotic rehabilitation intervention
Changes in Motricity Index for upper extremity
Time Frame: Before the intervention, after a 6-week robotic rehabilitation intervention
It is a validated measure of upper limb strength. It ranges from 0 (worse) to 100 (normal strength).
Before the intervention, after a 6-week robotic rehabilitation intervention
Changes in EEG-based Interhemispheric coupling index
Time Frame: Before the intervention, after a 1-hour robotic rehabilitation session
Interhemispheric coupling evaluated by means of 64-channel Electroencephalogram (EEG)
Before the intervention, after a 1-hour robotic rehabilitation session
Changes in EEG-based Interhemispheric coupling index
Time Frame: Before the intervention, after a 6-week robotic rehabilitation intervention
Interhemispheric coupling evaluated by means of 64-channel Electroencephalogram (EEG)
Before the intervention, after a 6-week robotic rehabilitation intervention
Changes in EEG-based Interhemispheric coupling index
Time Frame: Before the intervention, 1 week after the end of the 30-session robotic intervention
Interhemispheric coupling evaluated by means of 64-channel Electroencephalogram (EEG)
Before the intervention, 1 week after the end of the 30-session robotic intervention
Changes in EEG-based Connectivity index
Time Frame: Before the intervention, after a 1-hour robotic rehabilitation session
Connectivity evaluated by means of 64-channel Electroencephalogram (EEG)
Before the intervention, after a 1-hour robotic rehabilitation session
Changes in EEG-based Connectivity index
Time Frame: Before the intervention, after a 6-week robotic rehabilitation intervention
Connectivity evaluated by means of 64-channel Electroencephalogram (EEG)
Before the intervention, after a 6-week robotic rehabilitation intervention
Changes in EEG-based Connectivity index
Time Frame: Before the intervention, 1 week after the end of the 30-session robotic intervention
Connectivity evaluated by means of 64-channel Electroencephalogram (EEG)
Before the intervention, 1 week after the end of the 30-session robotic intervention
Changes in Fugl-meyer Assessment - Sensory functioning
Time Frame: Before the intervention, after a 6-week robotic rehabilitation intervention
It is a stroke-specific, sensory impairment index. It ranges from 0 (worse) to 12points (best).
Before the intervention, after a 6-week robotic rehabilitation intervention
Changes in Modified Ashworth Scale
Time Frame: Before the intervention, after a 6-week robotic rehabilitation intervention
It is a validated measure of spasticity. It ranges from 0 (normal) to 4 (rigid limb).
Before the intervention, after a 6-week robotic rehabilitation intervention
Changes in Wolf Motor Function Test
Time Frame: Before the intervention, after a 6-week robotic rehabilitation intervention

It is a validated measure of upper extremity motor ability through timed and functional tasks.

The scores ranges from 0 to 75; lower scores are indicative of lower functioning levels.

Before the intervention, after a 6-week robotic rehabilitation intervention
Changes in Execution time (seconds) measured with the robot
Time Frame: Before the intervention, after a 6-week robotic rehabilitation intervention
It is the time (in seconds) required to perform reaching movement using the robot
Before the intervention, after a 6-week robotic rehabilitation intervention
Changes in Range of Motion (degrees) measured with the robot
Time Frame: Before the intervention, after a 6-week robotic rehabilitation intervention
It is the range of motion (measured in degrees) of shoulder and elbow evaluated using the robot
Before the intervention, after a 6-week robotic rehabilitation intervention
Changes in Number of velocity peaks measured with the robot
Time Frame: Before the intervention, after a 6-week robotic rehabilitation intervention
It is a measure of movement smoothness while performing reaching movements with the robot.
Before the intervention, after a 6-week robotic rehabilitation intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 10, 2022

Primary Completion (Anticipated)

September 1, 2022

Study Completion (Anticipated)

September 1, 2022

Study Registration Dates

First Submitted

November 10, 2021

First Submitted That Met QC Criteria

January 3, 2022

First Posted (Actual)

January 4, 2022

Study Record Updates

Last Update Posted (Actual)

April 29, 2022

Last Update Submitted That Met QC Criteria

April 22, 2022

Last Verified

April 1, 2022

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on Robotic rehabilitation using the Arm Light Exoskeleton Rehab Station (ALEx RS) and bimanual serious games

Subscribe